Background-Studies suggest that most hospitals now have relatively high adherence with recommended acute myocardial infarction (AMI) process measures. Little is known about hospitals with consistently poor adherence with AMI process measures and whether these hospitals also have increased patient mortality.
S everal initiatives have been launched in recent years to collect hospital performance data and make it widely available to the public. The practice that began more than 15 years ago in New York State 1 has become commonplace, as the Centers for Medicare and Medicaid Services (CMS) now publicly reports performance of hospitals nationally on their website, Hospital Compare (http://www.hospitalcompare.hhs. gov). One rationale for public reporting is that it will motivate low-performing hospitals to improve and encourage patients to select higher quality hospitals. 2 Yet questions linger about how to best assess hospital quality and motivate improvement.
Uncertainty remains about whether hospital performance is best measured using adherence to evidence-based process mea-sures or patient outcomes (eg, risk-adjusted mortality). [3] [4] [5] [6] [7] [8] [9] [10] [11] This uncertainty stems, in part, from conflicting data as to whether hospitals with better adherence with process measures have correspondingly better patient outcomes. 9 -11 In addition, it is unclear whether pay-for-performance initiatives based on adherence to process measures unfairly target lowperforming hospitals with limited resources for quality improvement programs (eg, safety-net hospitals). 12, 13 Whereas a number of prior studies have characterized hospitals' adherence with CMS process measures 4, [7] [8] [9] [10] [11] [13] [14] [15] [16] [17] and how adherence may be changing over time, [15] [16] [17] [18] to the best of our knowledge there are no studies specifically focusing on hospitals with consistently poor adherence. In particular, it is unclear how many hospitals have consistently low adherence with CMS process measures, whether these hospitals may face common challenges that were not considered in development of these performance measures, and whether patients treated in hospitals with poor adherence have higher mortality than patients treated in hospitals with better adherence. Furthermore, the identification of lowperforming hospitals may offer a particularly good opportunity to target investments in quality improvement in a small group of hospitals that offer the greatest opportunity for benefit.
Thus, our primary objective is to examine the organizational characteristics of hospitals with consistently low adherence with CMS process measures for AMI, as compared to US hospitals with intermediate and high performance. Our secondary objective is to examine characteristics and riskadjusted mortality of patients treated in low-performing hospitals, as compared to patients treated in intermediate-and high-performing hospitals.
WHAT IS KNOWN
• A number of recent studies have characterized hospitals' adherence with CMS process measures, and how adherence may be changing over time. Data ugggest that, while overall quality has improved over time, some hospitals seem to lag significantly behind. Yet little is known about the characteristics and outcomes of these hospitals. • Identification of low-performing hospitals may offer a particularly good opportunity to target investments in quality improvement in a small group of hospitals that offer the greatest opportunity for benefit.
WHAT THE STUDY ADDS
• Analyses provide evidence that low-performing hospitals differ substantially from better-performing US hospitals. Low-performing hospitals have different organizational characteristics, including lower bed numbers, lower staffing ratios and lower volumes, and are less likely to provide specialty services such as coronary revascularization. Low-performing hospitals have are more likely to be safety nets for vulnerable populations and appear to have somewhat worse mortality than other US hospitals. • Thus, the study suggests that, by targeting policy and quality improvement efforts at low-performing hospitals, there is a unique opportunity for improving patient outcomes and reducing disparities in health care.
Methods
The current study relied on 4 primary hospital-and patient-level data sources: (1) 
Hospital-Level Data
We first identified all hospitals reporting performance on AMI process measures during 2004 to 2006 through the Hospital Compare website (www.hospitalcompare.hhs.gov; nϭ3802). The Hospital Compare website provides performance information for most acute care nonfederal hospitals in the United States, including each hospital's adherence with 5 core AMI process measures: (1) use of aspirin within 24 hours of arrival; (2) use of aspirin at discharge; (3) use of ␤-blockers within 24 hours of arrival; (4) use of ␤-blockers at discharge; (5) the use of an angiotensin-converting-enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) for left ventricular systolic dysfunction. Although participation in Hospital Compare is voluntary, because CMS has created financial incentives for reporting most measures, participation is nearly universal. There are 3 additional AMI process measures (time-to-reperfusion with either thrombolytics or percutaneous coronary intervention [PCI], and smoking cessation counseling) that were not linked to financial incentives for reporting during the study period and fewer hospitals reported data for these measures; thus our analyses focused on adherence with the 5 core measures. For each hospital and each measure, the Hospital Compare database provides the number of patients eligible for each therapy and the number of eligible patients receiving that specific therapy; hospital performance is assessed as the proportion of eligible patients receiving each recommended therapy. We downloaded these publicly available data from the Hospital Compare web site. We excluded all hospitals at which the total number of AMI patients eligible for each of the 5 therapies was less than 25 (nϭ965) in accordance with similar methodology employed by CMS and other investigators, 7, 14 because such hospitals are considered to have too few cases to allow for a statistically reliable assessment of performance. The remaining 2837 hospitals were linked to the 2005 AHA Annual Survey using each hospital's unique provider number. The AHA survey provided data on hospitals' structural and operational characteristics including teaching status, for-profit status, and bed size. We excluded 21 hospitals (Ͻ1% of the final sample) that we were unable to link to the AHA data.
Our analyses used a number of additional hospital characteristics that we derived from the data sources described above. We identified each hospital's location as urban or rural based on each hospital's zip code using rural-urban commuting area codes (http://www.ers.usda. gov/data/ruralurbancommutingareacodes). We categorized hospitals as safety-net providers if the hospital's Medicaid caseload for 2005 exceeded the mean for all US hospitals by 2 standard deviations of the overall distribution for the study hospitals (mean, 16.4%; SD, 9.6%), thus adapting a method that has been previously used in research. 12, 19 Finally, we calculated nurse staffing ratios for each hospital as nurse full-time equivalents (FTEs) divided by adjusted patient days. 20
Patient-Level Data
The study used 2 sources of patient-level data: (1) 2005 MedPAR data for characteristics and outcomes of AMI patients admitted to study hospitals; and (2) the US Census 2000 Summary File (publicly available at http://factfinder.census.gov) for zip code level SES measures for study patients.
We used the 2005 MedPAR data to identify all patients admitted to the study hospitals with AMI (International Classification of Diseases, Ninth revision, Clinical Modification [ICD-9-CM code 410.X]) during 2005; hospitals identified in the HQA data that could not be linked to the MedPAR data (nϭ76) were excluded. The MedPAR files contain patient-level data on all hospitalizations of fee-for-service Medicare enrollees including patient demographics, primary and secondary diagnoses; procedures; and discharge disposition. Patients in the MedPAR files are linked to the Medicare Denominator files to ascertain deaths occurring after hospital discharge. Deaths occurring after transfer were attributed to the initial admitting hospital rather than the receiving hospital.
We identified AMI location using ICD-9-CM diagnostic codes and comorbid illnesses following algorithms developed by Elixhauser et al. 21 We also calculated each hospital's Medicare AMI, PCI, and coronary artery bypass grafting (CABG) surgery volumes by summing the number of patients admitted to each hospital for each procedure in the MedPAR data. We assessed whether each hospital had full revascularization capability, defined as the performance of at least 2 PCI and 2 CABG procedures on Medicare enrollees during 2005.
We linked each patient's zip code of residence in the MedPAR files to 2000 US Census data to obtain socioeconomic measures (eg, mean household income) of patients admitted to the study hospitals. Zip code-based centroids were also used to calculate distances between patients' residences and admitting hospitals, and between admitting hospitals without revascularization and closest hospitals providing full revascularization services. The final sample included 2761 hospitals admitting 186 700 AMI patients.
Identification of Low-, Intermediate-, and High-Performing Hospitals
We assessed hospital compliance with AMI process measures by calculating a composite AMI score for each hospital and each year reflecting overall compliance with the 5 AMI measures described previously. Using the methodology adopted by Williams et al, 17 the scores were computed as the ratio of the number of patients in a given hospital who received each treatment divided by the number of patients in that hospital who were eligible for each treatment for all 5 measures in aggregate. Hospitals were then stratified into deciles based on their composite AMI score for each year (ie, 2004, 2005, and 2006 Lastly, we compared crude and adjusted 30-day mortality rates for AMI patients hospitalized in low-, intermediate-, and highperforming hospitals. Crude mortality rates were compared using the Cochran Armitage test for trend. Risk-adjusted 30-day mortality rates were constructed as the ratio of predicted to expected mortality at each hospital, multiplied by the mean overall 30-day mortality rate for this population (ie, hospital-specific risk-standardized mortality rates 22 ). Predicted and expected 30-day mortality were estimated using multivariable mixed models that controlled for patient sociodemographic characteristics and comorbidity using fixed coefficients, and individual hospital effects using random hospital coefficients. Thus, expected mortality at a given hospital reflects the expected probability of death based on patient characteristics and is independent of hospital, whereas predicted mortality reflects the mortality for patients with the same characteristics at the specific hospital. Potential patient risk factors associated with mortality were identified in bivariate analyses (PϽ0.01) or from previous studies.
Candidate predictors included socio-demographic characteristics (age, gender, race, and median household income) comorbid conditions (as defined by Elixhauser et al), and location of myocardial infarction (categorized into 4 groups defined by ICD-9-CM codes, indicating anterior or lateral, inferior or posterior, subendocardial, or other unspecified locations). We then introduced variables significantly associated with mortality into a stepwise multivariate logistic model. For our risk-adjustment models, we retained all variables independently (PϽ0.01) related to mortality, with the exception of variables for which the observed relationships were not consistent with previously demonstrated clinical effects (eg, lower risk of death for a comorbidity known to increase the risk of death). Covariates included in the final model are displayed in supplemental Table I . Hospital-level risk-standardized mortality rates were compared across the 3 hospital performance categories using analysis of variance.
To examine the robustness of our findings, we performed several sensitivity analyses. We repeated the analyses using alternative thresholds for defining low-and high-performing hospitals as the bottom, respectively, top 15%, 20%, and 25% hospitals based on their composite performance score. We also repeated our analyses after excluding all patients initially admitted with AMI and subsequently transferred to another acute care facility because such patients may differ systematically from patients who do not require transfer.
Probability values were 2-sided. Statistical significance was defined using a conservative criterion of PϽ0.01. All analyses were performed using SAS statistical software version 9.1. This project was approved by the University of Iowa Institutional Review Board.
Results
Mean composite AMI process adherence ranged from 68% among low-performing hospitals to 99% among highperforming hospitals (Figure 1 ). Low-performing hospitals differed significantly from intermediate-and high-performing hospitals with respect to most hospital characteristics (Table  1 ). In particular, low-performing hospitals were more likely to be for-profit and were more likely to be defined as safety-net providers; interestingly, only 5 low-performing hospitals were both for-profit and safety-net providers.
Hospitals with low AMI performance were much less likely to offer full revascularization services (PCI and CABG) as compared to intermediate-and high-performance hospitals (6.7% [nϭ6] versus 51.4% [nϭ1052] versus 77.8% [nϭ49]; PϽ0.001). Low-performing hospitals without revascularization services were located further away from the nearest hospital with full revascularization services as compared with intermediate-and high-performing hospitals with- out revascularization services (mean, 25 versus 18 versus 14 miles, PϽ0.001).
The characteristics of Medicare beneficiares with AMI admitted to low-performing hospitals differed significantly from patients admitted to intermediate-and high-performing hospitals ( Table 2 ). In particular, patients admitted to low-performing hospitals tended to be older, were more likely to be female, black, reside in lower income zip codes, live further away from hospitals providing revascularization, and have higher rates of most comorbid illnesses. Patients admitted to low-performing hospitals were more likely to be transferred to another acute care hospital and less likely to receive revascularization within 30 days of admission as compared to patients admitted to intermediate-and highperforming hospitals (Table 3) . Low-performing hospitals had significantly higher unadjusted 30-day mortality rates as compared to intermediateand high-performing hospitals (Figure 2 and Table 4 ). After adjustment for patient characteristics, the risk of mortality in low-performing hospitals remained higher than intermediateand high-performing hospitals, but differences were modest. Results were similar when patients transferred out of the hospital were excluded from the analyses (Table 4 ). Sensitivity analyses using alternative definitions of low-, intermediate-, and high-performing hospitals did not significantly change our findings.
Discussion
Using linked data from Hospital Compare and Medicare, we found that hospitals with consistently low adherence to AMI process measures differ substantially from intermediate-and high-performing hospitals in a number of ways including hospital location, for-profit status, safety-net status, and availability of revascularization services. In addition, low performing hospitals serve a patient population that is older, more often black, and has more comoribid illness than higher performing hospitals. We found that hospitals with consis-tently low adherence with AMI process measures had higher mortality rates than better performing hospitals and that the higher mortality persisted after adjustment for patient risk factors, although differences across categories were more modest.
A number of our findings are important and merit further mention. First, our finding that low-performing hospitals appear organizationally different from higher-performing hospitals is important. Our data suggest that the category of low-performing hospitals are actually composed of 2 distinct subgroups. Many of the low-performing hospitals were small, rural, safety-net hospitals. At the same time, a substantial proportion of low-performing hospitals (nϭ31) were actually for-profit hospitals. This finding raises the question of why both safety-net and for-profit hospitals are over-represented among low-performing hospitals; it is likely that different mechanisms apply to each group.
It is well recognized that safety-net hospitals face significant financial constraints that have worsened in recent years. 23 Moreover, a recent study by Laschober et al 12 found evidence that smaller rural hospitals were less likely to have implemented formal quality improvement programs. Thus, it seems possible that safety-net hospitals lack the resources to engage in important quality improvement activities. The cause for poor performance of for-profit hospitals found in this study is somewhat less clear. Whereas some prior studies have found a negative association between hospital quality of care and for-profit ownership status, 7, 24 other studies have found outcomes in for-profit and not-for-profit hospitals to be quite similar. [25] [26] [27] [28] It is possible that for-profit hospitals might choose to distribute discretionary funds to their investors rather than invest in quality improvement, though such a strategy would seem risky if poor performance resulted in negative publicity and loss of market share. Alternatively, the finding could be explained by geographic variations in practice patterns, as most of the low-performing for-profit hospitals are located in the South (65%) and West (30%).
Our finding that low-performing hospitals had higher mortality rates than intermediate-and high-performing hospitals is also important. It is possible that low use of the evidence-based therapies captured by the process measures (eg, aspirin for AMI) is directly responsible for the higher mortality rates. Alternatively, it is possible that poor adherence to AMI process measures is the proverbial "canary in the coal mine," identifying hospitals that are having difficulty in 10 have reported a strong correlation between hospital compliance with AMI process measures and improved patient outcomes. Alternatively, Werner et al 11 found a far weaker correlation between hospital compliance and patient outcomes.
The policy implications of these data are important. In many ways the small group of low-performing hospitals offer an unique opportunity to improve patient outcomes by targeting quality improvement interventions on a discrete group of hospitals that generally serve a large number of vulnerable patients. Such interventions could include designing pay-forperformance programs to funnel payments to hospitals with the largest improvement rather than incentivizing hospitals based on their actual performance. In fact, the CMS Premier Hospital Quality Incentive Demonstration (HQID) pay-forperformance project is being revised to reward both top performance as well as improvement, which should provide strong incentive for low-performing hospitals. 30 Second, disproportionate share hospital (DSH) payments might be updated to incentivize safety-net hospitals to invest in quality improvement activities. 31 Additionally, because less than one fifth of these low-performing hospitals would be categorized as "safety-net" under current definitions, important research and policy questions arise as to how to better identify safety-net activities to allocate federal and local resources (eg, the Federal Medicaid DSH payments, and state-level uncompensated care pools) more judiciously. 32 Alternatively, one could make an argument that hospitals with consistently low performance merit more severe punitive action rather than remediation; taking such a tact would be politically challenging, but not unprecedented. 33 Future research should thus focus on understanding specific organizational issues related to poor performance, as well as on treatment choices for patients in markets with these lowperforming hospitals.
The study has several limitations that need to be acknowledged. First, the analysis was limited to 1 year of Medicare data, and hospitals reporting at least 25 AMI cases for the combined measures per year, representing only 63% of US hospitals treating AMI patients. Second, adherence to process measures are self-reported by hospitals and not subjected to independent external validation; recent articles have voiced concern over whether hospitals might be manipulating their results to enhance their apparent quality. Third, one could argue that our definitions of low-, intermediate-, and highperforming hospitals were based on somewhat arbitrary thresholds of AMI process measure compliance. Although this is technically correct, we conducted extensive sensitivity analyses using alternative definitions with similar results. Finally, mortality predictions are based on Medicare patients only and on the limited number of variables available within administrative data sets.
In summary, the current study provides evidence that hospitals with consistently low adherence with CMS AMI process measures differ substantially from better-performing US hospitals in terms of both hospital organizational characteristics and patient outcomes. Targeting quality improvement efforts at low-performing hospitals offers a unique opportunity for improving patient outcomes and reducing disparities in health care.
